Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 8346443.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The apolipoprotein E type 4 allele (APOE-epsilon 4) is genetically associated with the common late onset familial and sporadic forms of Alzheimer's disease (AD). Risk for AD increased from 20% to 90% and mean age at onset decreased from 84 to 68 years with increasing number of APOE-epsilon 4 alleles in 42 families with late onset AD. Thus APOE-epsilon 4 gene dose is a major risk factor for late onset AD and, in these families, homozygosity for APOE-epsilon 4 was virtually sufficient to cause AD by age 80.
Medical subject headings
- Alleles
- Alzheimer Disease
- Apolipoproteins E
- Gene Frequency